A short interview excerpt on hypoglycaemia risk for people with diabetes using GLP-1 receptor agonists, with the full talk on video and Spotify.
Recap by typeshit. Post by @medicalupdateonline on Instagram.
Bikman argues the facial change reflects rapid weight loss in general and suggests using the drug as a short-term aid for carb cravings. His view, not settled fact.
A clip from CNN's Body Language where two doctors point to common missteps they say lead to side effects on GLP-1 drugs. The full episode is on CNN.
An NYU obesity doctor outlines what people considering Ozempic or similar drugs should watch for. It is a general explainer for anyone weighing the shots.
15:57
A video on Chinese supply behind the peptide trend and the open question of what is actually in the vials people buy.
A brief share flagging a study on GLP-1 medications and overdose as the opioid epidemic shifts, with few details given beyond the link.
Federal health officials are pushing forward with a plan to open up access to injectable peptides, a drug class that remains unproven.
Loading…